Scientists have developed a new gene therapy approach that offers tremendous promise for one day treating an eye disease that leads to blindness and affects thousands of people across the globe. Researchers from Trinity College Dublin and University College London…
Read More
Impressive result for mental health therapy
The researchers evaluated the NewAccess program, which is an Australian adaptation of the United Kingdom’s IAPT (Improving Access to Psychological Therapies) approach of delivering low intensity therapies for symptoms of depression and anxiety—and the results have underlined its effectiveness. “The…
Read More
Charlamagne Tha God: Black Men "Constantly Deal With Anxiety"
May is Mental Health Awareness Month. For too long, men have been silent about mental health and it’s literally killing us. We can change that. Our Healthy Mind, Healthy Body series shines a light on mental health issues that everyone…
Read More
Abby Lee Miller Just Revealed She's 'Regressing' Every Day Without Physical Therapy
Abby Lee Miller posted a new Instagram video revealing she’s regressing without physical therapy. Abby Lee’s been in a wheelchair since April 2018, but she’s been showing off newfound mobility the last few months. She was diagnosed with Burkitt lymphoma,…
Read More
Findings in mice reveal possibilities for fetal drug therapy for deafness
New research led by hearing scientists at Oregon Health & Science University suggests an avenue to treat and prevent intractable genetic disorders before birth. Researchers at the Oregon Hearing Research Center, working with mice, injected a specially designed synthetic molecule…
Read More
Phone-based therapy beneficial for depression in Parkinson’s disease
Telephone-based cognitive behavioral therapy (T-CBT) seems to be an effective intervention for depression in Parkinson disease (PD), outperforming treatment-as-usual (TAU) on all depression, anxiety, and quality-of-life measures, according to a study published online April 1 in Neurology. Roseanne D. Dobkin,…
Read More
Combination drug therapy for childhood brain tumors shows promise in laboratory models
In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either…
Read More